Abera Bioscience

Abera Bioscience Intangible Assets

The Intangible Assets of Abera Bioscience (ABERA.SL) as of Oct 16, 2026 is 1.89 M SEK. In the previous year, Intangible Assets was 1.89 M SEK — a change of 0.00% (lower).

Intangible Assets

1.89 MSEK

YoY

0.00%

Last updated:

Intangible Assets of Abera Bioscience is 2025 1.89 M SEK. Intangible Assets of Abera Bioscience was 2024 1.89 M SEK. It decreases by 0.00% lower compared to the previous year.

The Abera Bioscience Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2018
1.89 M SEK
Jan 1, 2019
1.89 M SEK
Jan 1, 2020
1.89 M SEK
Jan 1, 2021
1.89 M SEK
Jan 1, 2022
1.89 M SEK
Jan 1, 2023
1.89 M SEK
Jan 1, 2024
1.89 M SEK
Jan 1, 2025
1.89 M SEK
The Abera Bioscience Intangible Assets history
YEARIntangible AssetsYoY
1.89 MSEK0.00%
1.89 MSEK0.00%
1.89 MSEK0.00%
1.89 MSEK0.00%
1.89 MSEK0.00%
1.89 MSEK0.00%
1.89 MSEK0.00%
1.89 MSEK0.00%
1.89 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Abera Bioscience Stock analysis

What does Abera Bioscience do? Abera Bioscience AB is a biotechnology company based in Uppsala, Sweden, operating within the healthcare sector. The company focuses on the research and development of pharmaceutical products, particularly in the field of vaccine development. It utilizes a proprietary vaccine delivery platform to advance vaccine candidates toward late pre-clinical or early clinical stages. Abera Bioscience aims to identify licensing partners for further development of its vaccine candidates. The company's technology is primarily applied in the development of vaccines targeting pneumococci and immunooncology. Abera Bioscience has a small operational footprint, employing five full-time staff members. It completed its initial public offering (IPO) on February 24, 2021, and is listed under the ticker ABERA.SL with ISIN SE0015245097. The company's headquarters are located in Uppsala, and it operates primarily within the Nordic market. Its website is https://aberabio.com/. The company's activities are centered on advancing vaccine candidates through its platform technology, with an emphasis on strategic partnerships for subsequent development phases. Abera Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Abera Bioscience stock

Intangible Assets of Abera Bioscience is 1.89 M SEK in 2025.

Intangible Assets of Abera Bioscience changed from 1.89 M SEK to 1.89 M SEK, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Abera Bioscience since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Abera Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Abera Bioscience

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Abera Bioscience